HIVE vs SLS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

HIVE

56.4
AI Score
VS
HIVE Wins

SLS

46.7
AI Score

Investment Advisor Scores

HIVE

56score
Recommendation
HOLD

SLS

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE SLS Winner
Forward P/E 62.8931 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 130.5% -82.5% HIVE
Earnings Growth -99.9% 0.0% SLS
Tradestie Score 56.4/100 46.7/100 HIVE
Profit Margin -49.9% 0.0% SLS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HIVE 1M: -18.2% · 3M: +17.4% SLS 1M: -24.6% · 3M: +102.2%

Current Technical Phase

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.0 · Price: $2.83

SLS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.0 · Price: $10.01

Fundamentals Snapshot

Metric HIVE SLS
Market Cap
Forward P/E -5.5 -80.8
Trailing P/E
Revenue (TTM)
Revenue Growth 1.3% -0.8%
Gross Margin 0.4%
Operating Margin -0.8% 0.0%
EPS -0.78 -0.21
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.